Investor · Austin, TX

Matthew Winkler

Open Matthew in the network graph →

Filings

10

SEC Form D

Connections

53

co-filers

Capital

$66.3M

across filings

Active

Aug 2011

to Oct 2018

Most-connected co-filers (53)

Lynne Hohlfeld · Austin, TX6 shared Ana C. Ward · Austin, TX6 shared Corey Goodman · Suite 595, CA6 shared Paul Lammers · Austin, TX5 shared Evan S. Melrose · Austin, TX3 shared Christopher D. Earl · Austin, TX3 shared Kim L. Korth · AUBURN HILLS, MI2 shared Lonnie Mayne · Salt Lake City, UT2 shared Charles Gottschalk · Seattle, WA2 shared William J. Barrett · Goshen, IN2 shared Wayne A. Whitener · Goshen, IN2 shared Robert W. Wilson · Goshen, IN2 shared Michael J. Powell · Billerica, MA2 shared Robert J. Campbell · Goshen, IN2 shared Edward Mathers · Cambridge, MA2 shared Kurtis Williams · Midvale, UT2 shared Crist J. Frangakis · Chapel Hill, NC2 shared Elaine Jones · Austin, TX2 shared Brian Mckelligon · Menlo Park, CA2 shared Garry Nolan · Menlo Park, CA2 shared Robert Shepler · Seattle, WA2 shared Herbert M. Gardner · Goshen, IN2 shared Glen D. Mella · Provo, UT2 shared Edward Flynn · Tualatin, OR2 shared

Recent filings (10)

Akoya Biosciences, Inc.Oct 2018 · 11 co-filers$25.5M Akoya Biosciences, Inc.Oct 2018 · 11 co-filers$25.5M Akoya Biosciences, Inc.Jul 2017 · 11 co-filers$9.0M Akoya Biosciences, Inc.Jul 2017 · 11 co-filers$9.0M Mirna Therapeutics, Inc.May 2015 · 22 co-filers$45.0M Mirna Therapeutics, Inc.May 2015 · 22 co-filers$45.0M ASURAGEN INCMar 2013 · 16 co-filers$15.0M Mirna Therapeutics, Inc.Nov 2012 · 14 co-filers$34.5M SUPREME INDUSTRIES INCJan 2012 · 16 co-filers$1.8M Mirna Therapeutics, Inc.Aug 2011 · 12 co-filers$1.5M ASURAGEN INCAug 2011 · 14 co-filers$10.0M Second Genome, Inc.Aug 2011 · 8 co-filers$5.0M Second Genome, Inc.Aug 2011 · 8 co-filers$5.0M SUPREME INDUSTRIES INCJun 2011 · 16 co-filers

Derived from public SEC Form D (Reg D) filings; entities resolved probabilistically. See Matthew in the interactive graph →